Genopathy
Gene-Disorder Association · Article
Gene
TP53
Tumor Protein P53
Disorder
Melanoma
Manually curatedApproved treatment annotated
Association Review

In brief

The association between TP53 (Tumor Protein P53) and Melanoma is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 2
Compounds 12
Trials 1,054of 10,454 via TP53 compounds
Publications 50
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
TP53

The gene

3 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Melanoma

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Population genetics

GWAS signals

3 GWAS phenotypes

Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.

Request access
06
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
07
Interventions

Therapeutics

12 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
08
Human studies

Clinical trials

10,454 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
09
Literature

Reading

50 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
10
Provenance

References & sources

20 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access